What class of drugs is known to enhance sexual desire in women with HSDD?

Testosterone analogs have been shown to enhance sexual desire in women diagnosed with Hypoactive Sexual Desire Disorder (HSDD). HSDD is characterized by a persistent lack of sexual interest that can lead to distress in affected women. Research indicates that testosterone plays a significant role in sexual function and desire among women, particularly those who might have lower levels of this hormone due to factors such as aging, hormonal changes, or surgical procedures affecting ovarian function.

Testosterone analogs, like transdermal patches or other formulations, aim to restore sexual desire by increasing circulating testosterone levels, thereby potentially improving libido and overall sexual satisfaction. This approach has gained attention as a targeted treatment option for women experiencing HSDD, addressing the hormonal component that might be contributing to their condition.

The other options do not align with the mechanism or therapeutic goal regarding enhancing sexual desire for women with HSDD. Antidepressants, while they can be used to manage mood disorders, sometimes have the side effect of lowering libido. Non-steroidal anti-inflammatory drugs are primarily used for pain relief and inflammation, with no direct link to enhancing sexual desire. Appetite suppressants focus on weight management and do not address sexual function. Hence, testosterone analogs are the most suitable option for enhancing